Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Sep;56(2):239-60.
doi: 10.1901/jeab.1991.56-239.

Distinguishing between haloperidol's and decamethonium's disruptive effects on operant behavior in rats: use of measurements that complement response rate

Affiliations

Distinguishing between haloperidol's and decamethonium's disruptive effects on operant behavior in rats: use of measurements that complement response rate

S C Fowler et al. J Exp Anal Behav. 1991 Sep.

Abstract

The behavioral effects of haloperidol (0.04 to 0.16 mg/kg) and nonparalytic doses of decamethonium (0.2 to 0.8 mg/kg) were studied with operant methods that permitted the measurement of response rate, peak force of response, duration of response, and duration of the rat's head entry into the reinforcement dipper well. Type of operant response topography (forelimb press or forelimb grasp-and-pull) and peak force (low or high) required for reinforcement delivery were independent variables. The low-force, press-topography condition yielded qualitatively different profiles for the two drugs. Haloperidol increased peak force and duration of operant response, increased maximum head entry duration, and temporally dissociated forelimb and head entry behavior. Decamethonium decreased force and duration of operant response, did not appreciably affect maximum head entry duration, and did not influence the normal temporal coupling of forelimb and head entry responses. The haloperidol effects were seen as reflections of pseudo-Parkinsonism, not muscle weakness, which appeared to be the primary source of decamethonium's behavioral effects.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1981 Mar 5;70(1):65-70 - PubMed
    1. Fed Proc. 1975 Aug;34(9):1880-8 - PubMed
    1. Pharmacol Biochem Behav. 1983 Nov;19(5):787-90 - PubMed
    1. Schizophr Res. 1990 May-Jun;3(3):173-86 - PubMed
    1. Pharmacol Biochem Behav. 1986 Oct;25(4):791-6 - PubMed

Publication types

LinkOut - more resources